中新网2月20日电 据中国政府网消息，国务院办公厅近日发布关于巩固完善基本药物制度和基层运行新机制的意见。意见要求，要定期调整国家基本药物目录，从严控制增补数量，不得将权限下放到市(地)、县(市、区)或基层医疗卫生机构。

February and, according to the Chinese government network news,The general office of the state council recently issued about consolidating improve essential drugs system and the basic operation mechanism is opinion.Opinion request,To regularly adjust national essential drugs list,Strictly control the number of supplement,May not access to the city(to)/county(city/area)Or basic medical and health institutions.

　　意见还要求，在增补品种时，要充分考虑基层常见病、慢性病用药与当地公立医院用药的衔接问题。

Opinion also requires,When the supplementary varieties,Fully consider the basic common diseases/Chronic drug use and local public hospital drug linking problem.

　　意见提到，要定期调整国家基本药物目录。按照防治必需、安全有效、价格合理、使用方便、中西药并重的原则，结合实际使用情况遴选调整国家基本药物目录，保持合理数量，优化品种结构。

Opinions mention,To regularly adjust national essential drugs list.According to the control must/Is safe and effective/Reasonable price/Easy to use/The principle of equal importance to traditional Chinese and western pharmaceutical,Based on the actual application to select adjusting national essential drugs list,Keep reasonable quantity,Improve the structure of grain varieties grown.

　　国家基本药物目录原则上每三年调整一次。省级人民政府统一增补本省(区、市)目录外药品品种，增补品种严格执行国家基本药物各项政策。

The national essential drug list every three years in principle is adjusted once.People's government at the provincial level in the province unified supplement(area/city)The directory drug varieties,Supplementary breed strictly implements national essential drugs policies.

　　意见强调，要严格执行诚信记录和市场清退制度。对在采购过程中提供虚假证明文件、蓄意抬高价格或恶意竞价、不按合同规定及时配送或供应质量不达标药品，以及向采购机构、医疗机构或个人进行贿赂或变相贿赂的企业，一律记录在案，依照有关法律法规严肃查处，并定期向社会公布查处结果。

Opinion emphasize,To strictly implement the credit records and the market system is to repel.In the purchasing process providing false documents/Deliberately raise prices or malicious bidding/As per the contract not timely delivery or supply the quality of drugs,And to the procurement agency/Medical institutions or individuals to bribery or disguised bribes enterprise,Are recorded,In accordance with relevant laws and regulations and serious,And regularly publish to the society and the results.

　　对于违反法律法规、被司法机关及行政机关查处的企业，两年内不得参与药品招标采购。

For violation of laws and regulations/By judicial organs and administrative organs and enterprise,Two years shall not participate in pharmaceutical bidding procurement.